18F-AzaFol

N/A

Report date: 2025/11/26 17:11:30
NME

Base Information

Drug Name18F-AzaFol
Drug Alias Name3′-aza-2′-[18F]fluorofolic acidAzaFol18F-AzaFol[18F]-AzaFol
ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Amino acid supplement, Lipids and VitaminsRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionPositron-emission tomography enhancersFolate receptor alpha binders
TargetsFolate receptor alpha
Therapy Area/IndicationsGiant Cell ArteritisLung NeoplasmsOvarian Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInsel Gruppe AG, University Hospital Bern
China Registration ClassN/A

Develop Information

Active CompaniesInsel Gruppe AG, University Hospital Bern
Inactive CompaniesUniversity Of LausanneLausanne University Hospital
Active IndicationsGiant Cell Arteritis
Inactive IndicationsLung NeoplasmsOvarian NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A